Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression

BMC Pulmonary Medicine

Taisheng Li¹  Wei Liu²  Na Zhou³  Yang Gao³  Yingyi Wang³  Zhao Sun³  Yuping Ge³  Chunmei Bai³  Xiaoyuan Li³  Rui Zhu⁴  Hongsheng Liu⁵  Changting Meng⁶ 

[1] Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, 100730, Beijing, China;Department of Intervention Group of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;Department of Medical Record, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, 100730, Beijing, China;Institute for Systems Biology, Seattle University, 98109, Seattle, WA, USA;

关键词: Immune cells;    NSCLC;    Cancer occurrence;    Advance cancer stage;    Clinicopathologic characteristics;   

DOI  :  10.1186/s12890-021-01636-x

来源: Springer

【 授权许可】

CC BY